口服補液鹽市場：依類型、應用、通路、地區劃分，2024-2031

2024-2031 年口服補液鹽市場評估

腹瀉、中暑和胃腸道感染等與脫水相關的症狀日益普遍，增加了對有效口服補液溶液的需求。 ORS 因其補充因這些病症而損失的液體和電解質的能力而受到廣泛認可，到 2024 年，其銷售額將超過 7.4297 億美元，到 2031 年將達到 17.471 億美元。

此外，衛生組織和政府提高了對 ORS 益處的認識並開展了教育活動，這有助於促進其使用，特別是在脫水率較高的地區。藥局和電子商務平台等分銷管道的擴展將增加可用性和可用性，加速市場成長，預計 2024-2031 年複合年增長率為 11.28%。

口服補液鹽市場定義/概述

口服補液鹽（ORS）是預防和治療脫水的治療藥物，特別是由腹瀉、嘔吐和熱應激引起的脫水。 ORS 由鹽和糖的精確混合物組成，溶解在水中後，有助於補充體內流失的液體和電解質。由於其有效性和易用性，ORS 廣泛應用於臨床和家庭。 ORS 的未來包括擴大在預防性衛生措施和緊急情況下的使用，特別是在脫水發生率較高的新興國家。配方和給藥方法的進步以及公眾意識和可用性的提高將推動 ORS 在全球範圍內的成長和採用。

衛生機構透過教育活動提高意識會促進口服補液鹽市場嗎？

衛生組織的教育活動推動人們的意識不斷提高，預計將顯著促進口服補液鹽 (ORS) 市場的發展。健康運動對於提高大眾對 ORS 在控制脫水方面的重要性的認識至關重要，特別是在腹瀉和相關疾病高發生率地區。例如，2023 年 9 月，世界衛生組織 (WHO) 發起了一項全球倡議，宣傳 ORS 的益處，強調其在降低脫水相關死亡率方面的有效性。這些努力不僅提高了人們對 ORS 的認識，還鼓勵其在臨床環境和家庭中的使用。教育措施強調 ORS 的正確使用和可近性，有助於增加需求和市場成長。

此外，當地衛生部和非政府組織 (NGO) 正在積極推動 ORS 在服務欠缺地區的使用。例如，2023 年 8 月，印度國家農村衛生團發起了一項重大運動，向農村人口宣傳 ORS 的可用性和益處。該活動成功增加了這些地區的 ORS 消費量，說明了公眾意識提高對市場擴張產生直接影響的更大趨勢。衛生組織越來越重視教育宣傳工作，有助於更好地向公眾提供信息，增加口服補液鹽的使用率，並推動市場向前發展。

日益增加的供應鏈問題是否會阻礙口服補液鹽市場的成長？

日益嚴重的供應鏈問題可能會擾亂製造和分銷流程，從而嚴重阻礙口服補液鹽 (ORS) 市場的成長。這些中斷可能會導致製造和運輸延誤，並限制關鍵地區 ORS 產品的供應。不可靠的供應可能會損害響應緊急需求的能力，特別是在脫水率高的地區。此外，供應鏈問題可能會增加營運成本，從而提高口服補液鹽產品的價格，並使低收入者更難獲得口服補液鹽。

此外，供應鏈中斷可能會損害 ORS 產品的品質和安全性。原料採購的延誤或問題可能會導致品質控制問題和使用不合格原料。這可能會削弱消費者信心，使我們受到監管審查，並使我們的市場擴張工作變得複雜。為了減輕這些風險，ORS 市場利害關係人必須投資於更具彈性的供應鏈策略，改善物流協調，並實施嚴格的品質控管程序。

目錄

第1章簡介

• 市場定義
• 市場區隔
• 調查方法

第 2 章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模與成長潛力
• 市場趨勢
• 市場推動因素
• 市場阻礙因素
• 市場機會
• 波特五力分析

第 4 章口服補液鹽市場：依類型

• 葡萄糖基 ORS
• 美國 ORS
• 基於柑橘的 ORS
• 針對特定醫療狀況的客製化處方

第 5 章口服補液鹽市場：依應用分類

• 治療腹瀉引起的脫水
• 嘔吐脫水的治療
• 運動時補充水分
• 劇烈運動後補充水分

第 6 章口服補液鹽市場：依通路分割

• 藥房
• 醫院和診所
• 線上零售平台
• 超商、便利商店

第7章區域分析

• 北美
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳大利亞
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東/非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第 8 章市場動態

• 市場推動因素
• 市場阻礙因素
• 市場機會
• 新冠肺炎 (COVID-19) 對市場的影響

第9章競爭態勢

• 主要公司
• 市佔率分析

第10章公司簡介

• Otsuka Pharmaceutical Co. Ltd.
• Monico Spa
• Gebro Pharma AG
• Primmed B.V.
• KBI Pharmaceuticals GmbH & Co. KG
• Nutriset
• Clinova Ltd.
• FDC Limited
• Watson Pharma（part of AbbVie）
• Sanofi S.A.

第 11 章市場前景與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章附錄

• 縮寫列表
• 來源與參考文獻

Oral Rehydration Salts Market Valuation - 2024-2031

The rising prevalence of dehydration-related conditions, such as diarrhea, heat exhaustion, and gastrointestinal infections, is increasing demand for effective rehydration solutions. ORS is widely recognized for its ability to replenish fluids and electrolytes lost as a result of these conditions surpassing USD 742.97 Million in 2024 and reachingUSD 1747.1 Million by 2031.

Furthermore, increased awareness and educational campaigns about the benefits of ORS by health organizations and governments help to promote its use, especially in areas with high rates of dehydration. The expansion of distribution channels, such as pharmacies and e-commerce platforms, increases accessibility and availability, accelerating market growth is expected to grow at aCAGR of about 11.28% from 2024 to 2031.

Oral Rehydration Salts Market: Definition/ Overview

Oral Rehydration Salts (ORS) are a medical treatment that prevents and treats dehydration, particularly when caused by diarrhea, vomiting, or heat stress. They are made up of a precise mixture of salts and sugars that, when dissolved in water, help replenish the body's lost fluids and electrolytes. Because of its effectiveness and ease of use, ORS is widely used in clinical settings as well as at home. The future of ORS includes increased use in preventive health measures and emergency situations, particularly in developing countries with high rates of dehydration. Advances in formulation and delivery methods, as well as increased public awareness and accessibility, are expected to drive ORS's global growth and adoption.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Rising Awareness of Educational Campaigns by Health Organization Propel the Oral Rehydration Salts Market?

Rising awareness, fueled by educational campaigns from health organizations, is expected to significantly boost the Oral Rehydration Salts (ORS) market. Health campaigns are critical in raising public awareness of the importance of ORS in managing dehydration, especially in areas with high rates of diarrhea and related conditions. For instance, in September 2023, the World Health Organization (WHO) launched a global initiative to promote the benefits of ORS, emphasizing its effectiveness in lowering dehydration-related mortality rates. Such initiatives not only raise awareness of ORS, but also encourage its use in clinical and home settings. The educational efforts emphasize proper use and accessibility of ORS, which contributes to increased demand and market growth.

Furthermore, local health departments and non-governmental organizations (NGOs) have actively promoted ORS use in underserved areas. For instance, in August 2023, India's National Rural Health Mission launched a major campaign to educate rural populations about the availability and benefits of ORS. This campaign has successfully increased ORS consumption in these communities, demonstrating a larger trend in which increased public awareness has a direct impact on market expansion. The growing emphasis on educational outreach by health organizations ensures a better-informed public and drives ORS adoption, propelling the market forward.

Will Rising Supply Chain Issues Hinder the Growth of the Oral Rehydration Salts Market?

Rising supply chain issues may significantly impede the growth of the oral rehydration salts (ORS) market by disrupting the manufacturing and distribution processes. These disruptions can cause delays in manufacturing and shipping, limiting the availability of ORS products in critical regions. Inconsistent supply can impair the market's ability to respond to urgent needs, especially in areas with a high incidence of dehydration-related conditions. Furthermore, supply chain issues may raise operational costs, resulting in higher ORS product prices and potentially limiting accessibility for low-income populations.

Furthermore, supply chain disruptions can compromise the quality and safety of ORS products. Delays or problems with raw material procurement can result in quality control issues or the use of substandard ingredients. This can erode consumer trust and result in regulatory scrutiny, complicating market expansion efforts. To mitigate these risks, stakeholders in the ORS market must invest in more resilient supply chain strategies, improve logistical coordination, and implement strict quality control procedures.

Category-Wise Acumens

Will Rising Demand of Glucose-Based ORS Propel the Growth of Oral Rehydration Salts Market?

The rising demand for glucose-based Oral Rehydration Salts (ORS) is expected to significantly boost the oral rehydration salts market. Glucose-based ORS is becoming increasingly popular due to its superior effectiveness in rehydrating and restoring electrolytes compared to traditional formulations. This preference stems from a growing understanding of the benefits of glucose in aiding the absorption of sodium and water in the intestine.

In July 2024, HealthPlus Pharmaceuticals introduced a new line of glucose-based ORS aimed at improving rehydration efficiency and patient compliance. This product introduction is consistent with the broader trend toward advanced ORS formulations. Furthermore, in August 2024, the World Health Organization (WHO) updated its ORS guidelines, recommending glucose-based formulations for improved dehydration treatment efficacy. This endorsement from a leading global health authority is expected to increase market adoption and growth. Such developments reflect a significant shift in the ORS market toward glucose-based solutions, which are characterized by superior performance and strong institutional support.

However, custom formulations for specific medical conditions are the fastest growing segment. This growth is being driven by an increase in demand for personalized healthcare solutions that are tailored to individual medical needs and conditions. Custom ORS formulations are gaining popularity because they provide targeted treatment options for health issues other than general dehydration, such as specific electrolyte imbalances and chronic illnesses. This trend reflects a shift toward more specialized and effective therapeutic solutions, which address a wider range of medical conditions and improve patient outcomes.

Will Rising Sales within Pharmacies Dominate the Oral Rehydration Salts Market?

Pharmacy sales are expected to continue to dominate the oral rehydration salts (ORS) market due to their established role as primary points of sale for health-related products. Pharmacies provide easy access to ORS, which is critical for consumers who require immediate treatment for dehydration, particularly in emergency situations. The widespread availability of ORS in pharmacies ensures that it remains the primary source of relief for people suffering from dehydration caused by conditions such as diarrhea or vomiting. This dominance is reinforced by pharmacies' ability to provide expert advice and guidance on the proper use of ORS products, which increases consumer trust and preference.

Furthermore, major pharmacy chains like Walgreens and CVS have expanded their ORS product lines in response to rising consumer demand. In June 2024, Walgreens announced a new partnership with a leading ORS manufacturer to increase inventory and ensure consistent supply across its stores, reflecting the growing importance of pharmacies as critical distribution points. This focus on pharmacies emphasizes their critical role in driving the ORS market, which has been supported by recent industry strategic moves.

Online retail platforms are the fastest growing market segment. This rapid growth is being driven by an increasing shift toward e-commerce, which is driven by consumer preferences for convenience and the ability to easily compare products and prices. Online platforms provide a diverse range of ORS products, including custom formulations and specialized options, appealing to a growing number of consumers seeking personalized solutions and home delivery services. This trend demonstrates the growing importance of digital shopping in meeting consumer needs and preferences.

Country/Region-wise

Will High Prevalence of Dehydration-Related Conditions in Asia Pacific Drive the Oral Rehydration Salts Market?

The high prevalence of dehydration-related conditions in Asia Pacific is fueling the oral rehydration salts (ORS) market. The region experiences frequent bouts of diarrhea and dehydration, especially in low-income and rural areas, necessitating a steady supply of ORS to effectively manage these conditions. Government initiatives and international health organizations are actively promoting ORS as a cost-effective treatment for dehydration, which is contributing to increased demand. For instance, in August 2023, the World Health Organization (WHO) expanded its ORS distribution programs in India and Bangladesh, with the goal of lowering dehydration-related mortality rates. This ongoing support emphasizes ORS's critical role in managing public health crises in the region.

Additionally, in September 2023, India's Ministry of Health and Family Welfare launched a new campaign to increase ORS availability and accessibility in rural health centers. This initiative is part of a larger strategy to improve maternal and child health, highlighting the growing importance of ORS as a key component of national health programs. The combination of high disease prevalence and strong government and international support is driving the growth of the ORS market in Asia Pacific, making it a critical region for market expansion and development.

Will Increasing Awareness of ORS Application in North America Propel the Oral Rehydration Salts Market?

The growing awareness of oral rehydration salts (ORS) applications in North America is expected to drive the ORS market significantly. In recent years, ORS has gained recognition as an effective solution for managing dehydration caused by gastrointestinal conditions, as well as for sports and exercise-related hydration. For instance, in June 2023, the United States Food and Drug Administration (FDA) approved new guidelines for the use of ORS in sports medicine, recognizing its benefits for athletes and active people. This endorsement has increased consumer awareness, resulting in a surge in demand for ORS products in pharmacies and sports nutrition stores.

Furthermore, educational campaigns and collaborations between health organizations and ORS manufacturers have played an important role in raising awareness. In August 2024, the Centers for Disease Control and Prevention (CDC) launched a major health initiative aimed at promoting ORS use for preventing dehydration in both children and adults, thereby boosting market growth. These efforts are bolstered by an increasing number of retail and online platforms that sell ORS products, making them more accessible to the North American public and propelling the market forward.

Competitive Landscape

The competitive landscape of the oral rehydration salts (ORS) market is characterized by a diverse array of companies offering various formulations to meet the growing demand. Companies are focusing on innovation, such as improving the taste and efficacy of ORS products, and expanding their distribution networks to enhance market reach. Additionally, partnerships with healthcare organizations and government initiatives to promote ORS use in combating dehydration are influencing the competitive dynamics. The market is also seeing increased investment in research and development to cater to specific regional needs and address emerging health challenges.

Some of the prominent players operating in the oral rehydration salts market include:

Otsuka Pharmaceutical Co. Ltd.

Monico Spa

Gebro Pharma AG

Primmed B.V.

KBI Pharmaceuticals GmbH & Co. KG

Nutriset

Clinova Ltd.

FDC Limited

Watson Pharma

Sanofi S.A.

Latest Developments

In February 2024, Procter & Gamble has announced the release of a new ORS formula aimed at improving taste and effectiveness. The new formula aims to improve patient compliance, especially in pediatric applications. This development is likely to increase P&G's market share in the ORS segment.

In July 2024, UNICEF has launched a new ORS distribution program geared toward emergency relief operations in conflict zones. The program seeks to address acute dehydration crises in affected areas through increased donations and international cooperation.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Oral Rehydration Salts Market, By Type

• Glucose-based ORS
• Rice-based ORS
• Citrus-based ORS
• Custom formulations for specific medical conditions

5. Oral Rehydration Salts Market, By Application

• Treatment of dehydration due to diarrhea
• Treatment of dehydration due to vomiting
• Sports hydration
• Rehydration after strenuous physical activity

6. Oral Rehydration Salts Market, By Distribution Channel

• Pharmacies
• Hospitals and clinics
• Online retail platforms
• Supermarkets and convenience stores

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Otsuka Pharmaceutical Co. Ltd.
• Monico Spa
• Gebro Pharma AG
• Primmed B.V.
• KBI Pharmaceuticals GmbH & Co. KG
• Nutriset
• Clinova Ltd.
• FDC Limited
• Watson Pharma (part of AbbVie)
• Sanofi S.A.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References